HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nelson Duran Selected Research

Nelson Duran Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 12/2006
2Non-Muscle Invasive Bladder Neoplasms
01/2016 - 01/2015
1Granuloma
01/2024
1Vascular Diseases (Vascular Disease)
07/2022
1Peripheral Nervous System Diseases (PNS Diseases)
07/2022
1Reinfection
07/2016
1Cystic Fibrosis (Mucoviscidosis)
07/2016
1Inflammation (Inflammations)
01/2015
1Malaria
01/2015
1Carcinogenesis
01/2015
1Infections
03/2014
1Parasitemia
05/2009
1Leukemia
12/2006
1Colonic Neoplasms (Colon Cancer)
12/2006

Drug/Important Bio-Agent (IBA)

3violaceinIBA
01/2022 - 12/2006
2Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 07/2016
2InterferonsIBA
01/2016 - 01/2015
2P-mapaIBA
01/2016 - 01/2015
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2015
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2016 - 01/2015
1ChitosanIBA
01/2022
1Lipase (Acid Lipase)FDA Link
01/2022
1Levofloxacin (Levaquin)FDA Link
07/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
1EndostatinsIBA
01/2016
1Immunologic Factors (Immunomodulators)IBA
01/2016
1Protein AggregatesIBA
01/2015
1palmitoleic acidIBA
01/2015
1AndrogensIBA
01/2015
1AnhydridesIBA
01/2015
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2015
1Flutamide (Eulexin)FDA LinkGeneric
01/2015
1Hormones (Hormone)IBA
01/2015
1Ligases (Synthetase)IBA
01/2015
1MagnesiumIBA
01/2015
1Androgen Receptors (Androgen Receptor)IBA
01/2015
1Estrogen ReceptorsIBA
01/2015
1SteroidsIBA
01/2015
1CytokinesIBA
01/2015
1UbiquitinIBA
01/2015
1Co-Repressor ProteinsIBA
01/2015
1Ammonium CompoundsIBA
01/2015
1SilverIBA
03/2014
1Anti-Infective Agents (Microbicides)IBA
03/2014
1Chloroquine (Aralen)FDA LinkGeneric
05/2009
1Cytochromes c (Cytochrome c)IBA
12/2006
1Cysteine (L-Cysteine)FDA Link
12/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2006

Therapy/Procedure

3Therapeutics
01/2024 - 01/2015
2Immunotherapy
01/2016 - 01/2015
1Glycemic Control
07/2022
1Chemoprevention
01/2012